At six months , in the NLT group there were nine patients ( 82 % ) on high dose and one patient ( 9 % ) on low dose beta-adrenergic receptor blocker compared to the UC group with five ( 42 % ) patients reaching maximum dose and five ( 42 % ) patients on low dose ( p = 0.04 ) .